3 Endocrine Treatment of Prostate Cancer

This publication has 61 references indexed in Scilit:

• Treatment of patients with advanced cancer of the prostate: Phase III trial, zoladex against castration; a study of the British prostate group
  Journal of Steroid Biochemistry, 1987
• Adrenal androgen blockade in relapsed prostate cancer
  European Journal of Cancer and Clinical Oncology, 1985
• TREATMENT OF PATIENTS WITH ADVANCED CANCER OF THE PROSTATE USING A SLOW-RELEASE (DEPOT) FORMULATION OF THE LHRH AGONIST ICI 118630 (ZOLADEX®)
  Journal of Endocrinology, 1984
• Therapeutic significance and the mechanism of action of the LH-RH agonist ICI 118630 in breast and prostate cancer
  Journal of Steroid Biochemistry, 1984
• Treatment with gonadotrophin releasing hormone analogue in advanced prostatic cancer.
  BMJ, 1983
• Subcapsular Orchidectomy for Carcinoma of the Prostate¹
  British Journal of Urology, 1977
• Inhibition of testicular luteinizing hormone receptor level by treatment with a potent luteinizing hormone-releasing hormone agonist or human chorionic gonadotropin
  Biochemical and Biophysical Research Communications, 1977
• STRUCTURE OF A HYPOTHALAMIC PEPTIDE POSSESSING GONADOTROPIN‐RELEASING ACTIVITY
  International Journal of Peptide and Protein Research, 1972
• Structure of the porcine LH- and FSH-releasing hormone. II. Confirmation of the proposed structure by conventional sequential analyses
  Biochemical and Biophysical Research Communications, 1971
• Purification, amino acid composition and N-terminus of the hypothalamic luteinizing hormone releasing factor (LRF) of ovine origin
  Biochemical and Biophysical Research Communications, 1971